FARCO-PHARMA is a worldwide supplier of products for urology and outpatient medical treatment of patients. Our products, including medicinal products and medical devices, are used in the preventive treatment, therapy, and care of critically and chronically ill patients.
FARCO-PHARMA headquarters is in Cologne; production takes place at our facility in Berlin.
As the market leader and specialist for urological lubricants in Germany, we have focused on urological issues that we are able to innovatively and reliably address through up-close and personal collaboration with experts in many cases.
Intensive collaboration with urologists has resulted in products that not only meet the highest standards of pharmaceutical purity and quality, but also satisfy the requirements of needs-based implementation with respect to practical applications. In this regard, we have optimised the application systems for our products, as well as our sterile production processes and our patented process of sterilisation in the final container. This enables our lubricants to be supplied in sterile, ready-to-use syringes with ergonomically formed cones. As a result, they are easy and safe to handle, thus reducing the risk of injury and infection to a minimum.
In addition to lubricants, the FARCO-PHARMA product range includes also three sterile solutions for catheter inflation. As a certified manufacturer of sterile single-use syringes for urological applications, we meet all of the international market requirements through our production activities at GMP-certified production sites and the certification of our quality assurance system and medical devices in accordance with DIN EN ISO 13485 in compliance with European law. Our long-standing products, such as Instillagel® and Endosgel®, as well as our innovative products, such as Farco-fill Protect®, meet the highest pharmaceutical quality standards.
We supply about 900 customers in the medical and clinical sectors within Germany alone and ensure the care of a variety of patients with urological and gynaecological disorders.
With the objective of becoming active on the international market in accordance with our philosophy "Serving urology", FARCO-PHARMA expanded the sales of Instillagel® to other European countries early on. The first export market for Instillagel® was Austria in 1970. This was followed by Switzerland in 1973 and the Netherlands, Belgium, and Luxembourg in 1974.
In 1989, Hungary became our first eastern European market. And just one year later, in 1990, Hong Kong became the first overseas market for our products. Additional countries followed, especially Asian countries, including United Arab Emirates, Indonesia, Kuwait, South Korea, but also Canada, Australia, New Zealand, Mexico, and many others.
Another milestone for our international activities came in 2014. The U.S. Food and Drug Administration (FDA) completed its regulatory inspection of the production site in Berlin and issued FARCO-PHARMA approval for the marketing of a sterile lubricant in disposable syringes in the United States. We have been producing and selling the sterile catheter lubricant under the brand name GLYDO® on the U.S. market since October 2014. Medicinal products for the U.S. market are manufactured at the same production site and conform to the same high quality standards as those for other well-known FARCO-PHARMA products, such as Instillagel® and Endosgel® for the German and European markets.
Today, our products are sold on every continent and we have access to a global network of 44 exclusive distribution partners.
Corporate Head Office
FARCO-PHARMA, Production video "Lubricants in urology"